Is dementia reversible in patients with neurocysticercosis?

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 8, 2005, Pages 1164-1166

  Ramirez Bermudez, J ^a   Higuera, J ^a   Sosa, A L ^a   Lopez Meza, E ^a   Lopez Gomez, M ^a   Corona, T ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; STEROID;

ADULT; AGED; AGING; ARTICLE; BRAIN INJURY; CEREBROSPINAL FLUID EXAMINATION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROCYSTICERCOSIS; NEUROIMAGING; PARIETAL LOBE; PRIORITY JOURNAL; SOCIOECONOMICS; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 23144441816     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.052126     Document Type: Article

References (25)

1. Sotelo J, Del Brutto OH. Brain cysticercosis. Arch Med Res 2000;31:3-14.
2. Richards FO Jr, Schantz PM, Ruiz-Tiben E, Sorvillo FJ. Cysticercosis in Los Angeles County. JAMA 1985;254:3444-8.
3. Del Brutto OH, Santibañez R, Noboa CA, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42:389-92.
4. Cantu C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 1996;53:233-9.
5. Nieto D. Cysticercosis of the nervous system. Diagnosis by means of the spinal fluid complement fixation test. Neurology 1956;6:725-38.
6. Forlenza OV, Filho AHGV, Nobrega JPS, et al. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurq Psychiatry 1997;62:612-16.
7. Tavares Jr AR. Psychiatric disorders in neurocysticercosis [letter]. Br J Psychiatry 1993;163:839.
8. Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow-up of 450 cases. Medical Research Council Special Report Series No 299. London: Her Majesty's Stationery Office, 1961:1-58.
9. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. Arch Intern Med 1985;145:442-5.
10. Varma A, Gaur KJ. The clinical spectrum of neurocysticercosis in the Uttaranchal region. J Assoc Phys India 2002;50:1398-400.
11. Jha S, Patel R. Some observations on the spectrum of dementia. Neurol India 2004;52:213-14.
12. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-83.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
14. Kiernan RJ, Mueller J, Langston JW, et al. The Neurobehavioral Cognitive Status Examination: a brier but differentiated approach to cognitive assessment. Ann Intern Med J 987;107:481-5.
15. Schwamm LH, Van Dyke C, Kiernan RJ, et al. The Neurobehavioral Cognitive Status Examination: comparison with CCSE and MMSE in a neurosurgical population. Ann Intern Med 1987;107:486-91.
16. Jorm AF, Jacomb PA. An informant questionnaire on cognitive decline in the elderly (IQCODE): sociodemographic correlates, reliability, validity and some norms. Psychol Med 1989;19:1015-22.
17. Jorm AF, Scott R, Cullen JS, et al. Performance of the IQCODE as a screening test for dementia. Psychol Med 1991;21:785-90.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th editon, DSM-IV. Washington, DC: American Psychiatric Association, 1994.
19. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1987;23:89-97.
20. Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696-701.
21. Sotelo J. Neurocysticercosis - is the elimination of parasites beneficial? N Engl J Med 2004;350:280-2.
22. Sotelo J, Escobedo F, Penagos P. Albendazole vs praziquantel for therapy for neurocysticercosis. Arch Neurol 1988;45:532-4.
23. Del Brutto OH. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients. J Neurol Neurosurg Psychiatry 1997;62:659-61.
24. Corona T, Lugo R, Medina R, et al. Single-day praziquantel therapy for neurocysticercosis. N Engl J Med 1996;334:125.
25. Lopez-Gomez M, Castro N, Jung H, et al. Optimization of the single-day praziquantel therapy for neurocysticercosis. Neurology 2001;57:1929-31.